Evidence map›Paper›PMID 31925927›Full record

ArticleJournal of diabetes investigation2020

Nicotinic acetylcholine receptor signaling regulates inositol-requiring enzyme 1α activation to protect β-cells against terminal unfolded protein response under irremediable endoplasmic reticulum stress.

Tatsuya Ishibashi, Shuhei Morita, Shohei Kishimoto, Shinsuke Uraki, Ken Takeshima, Yasushi Furukawa, Hidefumi Inaba, Hiroyuki Ariyasu, Hiroshi Iwakura, Hiroto Furuta and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Tatsuya IshibashiThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.ORCID https://orcid.org/0000-0001-8684-1545
Shuhei MoritaThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Shohei KishimotoThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Shinsuke UrakiThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Ken TakeshimaThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Yasushi FurukawaThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Hidefumi InabaThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Hiroyuki AriyasuThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Hiroshi IwakuraThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Hiroto FurutaThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.ORCID https://orcid.org/0000-0003-1657-3519
Masahiro NishiThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Feroz R PapaDepartment of Medicine, University of California, San Francisco, California, USA.
Takashi AkamizuThe First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
Wakayama Medical University · JPUniversity of California, San Francisco · US

Funding

Japan Diabetes Foundation (S.M)Japan Society for the Promotion of Science JP17H07033Japan Society for the Promotion of Science JP18K16242Smoking Research Foundation (T.A, H.A)
6 · The paper itself

Abstract

AIMS/

introductionUnder irremediable endoplasmic reticulum (ER) stress, hyperactivated inositol-requiring enzyme 1α (IRE1α) triggers the terminal unfolded protein response (T-UPR), causing crucial cell dysfunction and apoptosis. We hypothesized that nicotinic acetylcholine receptor (nAChR) signaling regulates IRE1α activation to protect β-cells from the T-UPR under ER stress. MATERIALS AND

methodsThe effects of nicotine on IRE1α activation and key T-UPR markers, thioredoxin-interacting protein and insulin/proinsulin, were analyzed by real-time polymerase chain reaction and western blotting in rat INS-1 and human EndoC-βH1 β-cell lines. Doxycycline-inducible IRE1α overexpression or ER stress agents were used to induce IRE1α activation. An α7 subunit-specific nAChR agonist (PNU-282987) and small interfering ribonucleic acid for α7 subunit-specific nAChR were used to modulate nAChR signaling.

resultsNicotine inhibits the increase in thioredoxin-interacting protein and the decrease in insulin 1/proinsulin expression levels induced by either forced IRE1α hyperactivation or ER stress agents. Nicotine attenuated X-box-binding protein-1 messenger ribonucleic acid site-specific splicing and IRE1α autophosphorylation induced by ER stress. Furthermore, PNU-282987 attenuated T-UPR induction by either forced IRE1α activation or ER stress agents. The effects of nicotine on attenuating thioredoxin-interacting protein and preserving insulin 1 expression levels were attenuated by pharmacological and genetic inhibition of α7 nAChR. Finally, nicotine suppressed apoptosis induced by either forced IRE1α activation or ER stress agents.

conclusionsOur findings suggest that nAChR signaling regulates IRE1α activation to protect β-cells from the T-UPR and apoptosis under ER stress partly through α7 nAChR. Targeting nAChR signaling to inhibit the T-UPR cascade may therefore hold therapeutic promise by thwarting β-cell death in diabetes.

Indexed as

AnimalsApoptosisCell LineEndoplasmic Reticulum StressEndoribonucleasesHumansInsulin-Secreting CellsProtective AgentsProtein Serine-Threonine KinasesRatsReceptors, NicotinicSignal TransductionUnfolded Protein ResponseEndoribonucleasesERN1 protein, humanProtective AgentsProtein Serine-Threonine KinasesReceptors, NicotinicInositol-requiring enzyme 1αNicotinic acetylcholine receptorPancreatic β cell

Identifiers

PMID31925927
PMCPMC7378412
OpenAlexW3000356298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.